Free Shipping on purchases over €100

La Roche Posay Effaclar Astringent Lotion 200 Ml

La Roche Posay Effaclar Astringent Lotion 200 Ml

Effaclar Astringent Lotion 200 ml is a skin care product designed to treat acne and improve the appearance of oily skin. It contains active ingredients, such as salicylic acid and LHA, which help to reduce excess oil.

SKU: 152700
-23%
18.20
€23.70

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

In the anti-acne routine, the key step is cleansing: a clean pore will prevent pimples from appearing. In addition, products should be used to regulate the skin's sebum and treat/prevent acne and its marks. Moisturising is essential for the treatment to continue working, as is the use of sunscreen, which prevents the condition from worsening and leaving marks.

0 products in total

INFO AND TECHNICAL SPECIFICATIONS

Effaclar Astringent Lotion 200 ml is a product manufactured by the La Roche-Posay cosmetics brand. It is specifically designed to help treat acne and improve the appearance of oily skin. The astringent lotion contains active ingredients that help to reduce excess oil on the skin, unclog pores and prevent the formation of new blemishes. Some of the key ingredients are salicylic acid and LHA (Lipo Hydroxy Acid). Salicylic acid is a chemical exfoliant that helps to remove dead skin cells and unclog clogged pores.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: La Roche-Posay Laboratoire Dermatologique
  • Vendor address: 1 Avenue Eugène Schueller, 93600 Aulnay-sous-Bois
  • Phone number: +33 1 46 88 50 00
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.